BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19161927)

  • 1. Appropriate proton pump inhibitor use among older adults: a retrospective chart review.
    George CJ; Korc B; Ross JS
    Am J Geriatr Pharmacother; 2008 Dec; 6(5):249-54. PubMed ID: 19161927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inappropriate prescription of proton pump inhibitors on two pulmonary medicine wards.
    van Vliet EP; Otten HJ; Rudolphus A; Knoester PD; Hoogsteden HC; Kuipers EJ; Siersema PD
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):608-12. PubMed ID: 18679061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitor utilization patterns in infants.
    Barron JJ; Tan H; Spalding J; Bakst AW; Singer J
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):421-7. PubMed ID: 18030207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands.
    van Boxel OS; Hagenaars MP; Smout AJ; Siersema PD
    Aliment Pharmacol Ther; 2009 Mar; 29(5):571-9. PubMed ID: 19035978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-prescribing of proton pump inhibitors among chronic users of NSAIDs in the UK.
    Suh DC; Hunsche E; Shin HC; Mavros P
    Rheumatology (Oxford); 2008 Apr; 47(4):458-63. PubMed ID: 18263598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic intent of proton pump inhibitor prescription among elderly nonsteroidal anti-inflammatory drug users.
    Dries AM; Richardson P; Cavazos J; Abraham NS
    Aliment Pharmacol Ther; 2009 Sep; 30(6):652-61. PubMed ID: 19573167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of national provider prescription of PPI gastroprotection among elderly NSAID users.
    Abraham NS; Hartman C; Castillo D; Richardson P; Smalley W
    Am J Gastroenterol; 2008 Feb; 103(2):323-32. PubMed ID: 18289200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitor discontinuation in long-term care.
    Linsky A; Hermos JA; Lawler EV; Rudolph JL
    J Am Geriatr Soc; 2011 Sep; 59(9):1658-64. PubMed ID: 21883102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of gastroprotection in patients discharged from hospital on nonsteroidal anti-inflammatory drugs.
    Coté GA; Norvell JP; Rice JP; Bulsiewicz WJ; Howden CW
    Am J Ther; 2008; 15(5):444-9. PubMed ID: 18806520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sociodemographic factors influence use of proton pump inhibitors among users of nonsteroidal anti-inflammatory drugs.
    van Boxel OS; Hagenaars MP; Smout AJ; Siersema PD
    Clin Gastroenterol Hepatol; 2009 Aug; 7(8):855-61. PubMed ID: 19465157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
    Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing the cost of proton pump inhibitors by adopting best practice.
    Hughes JD; Tanpurekul W; Keen NC; Ee HC
    Qual Prim Care; 2009; 17(1):15-21. PubMed ID: 19281670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada.
    Rahme E; Barkun A; Nedjar H; Gaugris S; Watson D
    Am J Gastroenterol; 2008 Apr; 103(4):872-82. PubMed ID: 18371130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-prescription of gastro-protectants in hospitalized patients: an analysis of what we do and what we think we do.
    Doherty GA; Cannon MD; Lynch KM; Ayoubi KZ; Harewood GC; Patchett SE; Murray FE
    J Clin Gastroenterol; 2010 Mar; 44(3):e51-6. PubMed ID: 19609216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitor use and risk of hip fractures in patients without major risk factors.
    Kaye JA; Jick H
    Pharmacotherapy; 2008 Aug; 28(8):951-9. PubMed ID: 18657011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults.
    Valuck RJ; Ruscin JM
    J Clin Epidemiol; 2004 Apr; 57(4):422-8. PubMed ID: 15135846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment patterns and symptom control in patients with GERD: US community-based survey.
    Chey WD; Mody RR; Wu EQ; Chen L; Kothari S; Persson B; Beaulieu N; Lu M
    Curr Med Res Opin; 2009 Aug; 25(8):1869-78. PubMed ID: 19530980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use and overuse of proton pump inhibitors in cirrhotic patients.
    Chavez-Tapia NC; Tellez-Avila FI; Garcia-Leiva J; Valdovinos MA
    Med Sci Monit; 2008 Sep; 14(9):CR468-72. PubMed ID: 18758417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of physician education and computer alert to improve targeted use of gastroprotection among NSAID users.
    Coté GA; Rice JP; Bulsiewicz W; Norvell JP; Christensen K; Bobb A; Postelnick M; Howden CW
    Am J Gastroenterol; 2008 May; 103(5):1097-103. PubMed ID: 18477341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.